Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04964063 · ClinicalTrials.gov registry record · NA
A Real-World Evidence Study to Evaluate Oral Health Related Quality of Life Using an Anti-Sensitivity Toothpaste
A NA study, sponsored by HALEON.
- Completed
- Registry status
- NA
- Development phase
- 655
- Enrollment target
NCT04964063 is a NA study that has completed, run by HALEON. The registered enrollment target is 655 participants.
The verdict
NCT04964063, a NA study, has completed, sponsored by HALEON.
- COMPLETED
- Registry status
- NA
- Development phase
- 655 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate changes in oral health-related quality of life (OHrQoL) in participants suffering from Dentinal Hypersensitivity (DH) symptoms following the use of anti-sensitivity toothpaste for 24 weeks.
Interventions
- OTHER Potassium Nitrate + Sodium Fluoride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 655 participants |
| Start Date | 2021-08-31 |
| Est. Completion | 2022-05-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04964063
The ClinicalTrials.gov registry entry for NCT04964063 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 655 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HALEON, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Potassium Nitrate + Sodium Fluoride is the first listed.
NCT04964063 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04964063 about?
NCT04964063 is a clinical study titled "A Real-World Evidence Study to Evaluate Oral Health Related Quality of Life Using an Anti-Sensitivity Toothpaste". The purpose of this study is to evaluate changes in oral health-related quality of life (OHrQoL) in participants suffering from Dentinal Hypersensitivity (DH) symptoms following the use of anti-sensitivity toothpaste for 24 weeks.
What is the current status of trial NCT04964063?
This trial is currently completed. It is a NA study. The enrollment target is 655 participants. The study started on 2021-08-31. Estimated completion is 2022-05-13.
What interventions are being tested in trial NCT04964063?
The interventions under investigation include: Potassium Nitrate + Sodium Fluoride (OTHER).
Who is sponsoring clinical trial NCT04964063?
This trial is sponsored by HALEON, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.